Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;32(9):1603-7.
doi: 10.2337/dc08-2140. Epub 2009 Jun 1.

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Affiliations

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Jay M Sosenko et al. Diabetes Care. 2009 Sep.

Abstract

Objective: We studied the incidence of dysglycemia and its prediction of the development of type 1 diabetes in islet cell autoantibody (ICA)-positive individuals. In addition, we assessed whether dysglycemia was sustained.

Research design and methods: Participants (n = 515) in the Diabetes Prevention Trial-Type 1 (DPT-1) with normal glucose tolerance who underwent periodic oral glucose tolerance tests (OGTTs) were followed for incident dysglycemia (impaired fasting glucose, impaired glucose tolerance, and/or high glucose levels at intermediate time points of OGTTs). Incident dysglycemia at the 6-month visit was assessed for type 1 diabetes prediction.

Results: Of 515 participants with a normal baseline OGTT, 310 (60%) had at least one episode of dysglycemia over a maximum follow-up of 7 years. Dysglycemia at the 6-month visit was highly predictive of the development of type 1 diabetes, both in those aged <13 years (P < 0.001) and those aged > or =13 years (P < 0.01). Those aged <13 years with dysglycemia at the 6-month visit had a high cumulative incidence (94% estimate by 5 years). Among those who developed type 1 diabetes after a dysglycemic OGTT and who had at least two OGTTs after the dysglycemic OGTT, 33 of 64 (52%) reverted back to a normal OGTT. However, 26 (79%) of the 33 then had another dysglycemic OGTT before diagnosis.

Conclusions: ICA-positive individuals with normal glucose tolerance had a high incidence of dysglycemia. Incident dysglycemia in those who are ICA positive is strongly predictive of type 1 diabetes. Children with incident dysglycemia have an especially high risk. Fluctuations in and out of the dysglycemic state are not uncommon before the onset of type 1 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Shown are cumulative incidence curves for the subsequent development of type 1 diabetes according to whether dysglycemia occurred at the 6-month visit. The actual proportion of those developing type 1 diabetes is shown for each curve. The cumulative incidence was significantly greater when dysglycemia occurred at the 6-month visit.
Figure 2
Figure 2
Shown are cumulative incidence curves for the development of type 1 diabetes according to whether participants were aged <13 or ≥13 years among those who were dysglycemic at the 6-month visit. The cumulative incidence was significantly higher in the younger age-group, with an estimate of 94% by 5 years in those children.

References

    1. Rosenbloom AL, Hunt SS, Rosenbloom EK, Maclaren NK: Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetes. Diabetes 1982; 31: 385– 387 - PubMed
    1. Beer SF, Heaton DA, Alberti KGMM, Pyke A, Leslie RDG: Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins. Diabetologia 1990; 33: 497– 502 - PubMed
    1. Sosenko J, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS: Diabetes Prevention Trial-Type 1 Study Group. Patterns of metabolic progression to type 1 diabetes in the diabetes prevention trial-type 1. Diabetes Care 2006; 29: 643– 649 - PubMed
    1. Diabetes Prevention Trial-Type 1 Diabetes Study Group Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685– 1691 - PubMed
    1. Diabetes Prevention Trial-Type 1 Diabetes Study Group Effects of oral insulin in relatives of patients with type 1 diabetes. Diabetes Care 2005; 28: 1068– 1076 - PubMed